EntropyIO Completes $14M Funding and Secures $40M HYPE Staking Support

iconKuCoinFlash
Share
This is the logo of the coin.
HYPE
$85.481.89%
AI summary iconSummary
EntropyIO has secured $14 million in funding led by Ribbit Capital, alongside $40 million in HYPE staking support. The first markets are now live on Hyperliquid, including the first liquid Anthropic trading pair. The project plans to expand into Pre-IPO startups, compute resources, listed companies, and global indices for 24/7 trading. Funding rates remain a key focus as the platform scales. This move comes amid shifting market sentiment, with the Fear & Greed Index showing mixed signals for traders.

Odaily Planet Daily reports that EntropyIO has announced the completion of a $14 million funding round led by Ribbit Capital, alongside $40 million in HYPE staking support, with the first markets now live on Hyperliquid.

EntropyIO announced the launch of its first liquid trading market for Anthropic, with plans to expand further to include pre-IPO startups, computing resources, publicly traded companies, and global indices, enabling 24/7 trading.

Team members come from Citadel Securities, Optiver, Polymarket, and Millennium, and have developed a liquidity-weighted oracle that dynamically adjusts the weight of external oracle prices based on market executable depth to improve price discovery and liquidity for new assets.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.